Lee, Ruth D.
Chen, Yi-Je
Nguyen, Hai M.
Singh, Latika
Dietrich, Connor J.
Pyles, Benjamin R.
Cui, Yanjun
Weinstein, Jonathan R.
Wulff, Heike
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R61NS123195, NS100294)
Article History
Received: 4 April 2023
Revised: 4 April 2023
Accepted: 5 April 2023
First Online: 24 April 2023
Declarations
:
: This study was approved by the University of California, Davis Institutional Animal Care and Use Committee and conduced in accordance with the IMPROVE guidelines for ischemic stroke in rodents.
: N/A
: N/A
: J.W. is listed as an inventor on US patent No. PCT/US18/16014, KCa3.1 inhibitor senicapoc for use in Treatment of Stroke Patients. Filed 1/30/2018.